This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Rivo Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rebecca Aron: Innovator in Neuropsychiatric Therapeutics
Introduction
Rebecca Aron is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of neuropsychiatric therapeutics through her innovative research and development of novel chemical compounds.
Latest Patents
Rebecca Aron holds a patent for her invention titled "Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors." This patent describes new chemical compounds that act as 5-HT2A receptor agonists. These compounds are designed to provide improved therapeutic profiles for treating various neuropsychiatric, neurological, and neurodegenerative disorders. The patent also outlines methods for the synthesis and pharmaceutical use of these compounds. She has 1 patent to her name.
Career Highlights
Rebecca is currently associated with Rivo Bio, Inc., where she continues her research and development efforts. Her work focuses on creating innovative solutions that address complex neurological challenges.
Collaborations
Rebecca collaborates with several professionals in her field, including her coworker Alan C. Gibbs. Their combined expertise enhances the potential impact of their research.
Conclusion
Rebecca Aron is a trailblazer in the field of neuropsychiatric therapeutics, with her innovative patent contributing to advancements in treatment options for various disorders. Her work at Rivo Bio, Inc. exemplifies her commitment to improving mental health through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile